2014
Regional Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Potential Role for Dynamic Magnetic Resonance Imaging as an Imaging Biomarker and a Survival Update from Two Prospective Clinical Trials
Konstantinidis I, Do R, Gultekin D, Gönen M, Schwartz L, Fong Y, Allen P, D’Angelica M, DeMatteo R, Klimstra D, Kemeny N, Jarnagin W. Regional Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Potential Role for Dynamic Magnetic Resonance Imaging as an Imaging Biomarker and a Survival Update from Two Prospective Clinical Trials. Annals Of Surgical Oncology 2014, 21: 2675-2683. PMID: 24664624, PMCID: PMC4516216, DOI: 10.1245/s10434-014-3649-y.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBevacizumabBile Duct NeoplasmsBile Ducts, IntrahepaticBiomarkers, TumorCholangiocarcinomaDexamethasoneFemaleFloxuridineFollow-Up StudiesHumansInfusions, Intra-ArterialMagnetic Resonance ImagingMaleMiddle AgedNeoplasm StagingPrognosisProspective StudiesRetrospective StudiesSurvival RateConceptsUnresectable intrahepatic cholangiocarcinomaHepatic arterial infusionIntrahepatic cholangiocarcinomaDCE-MRIMagnetic resonance imagingMedian hepatic progression-free survivalClinical trialsHepatic progression-free survivalContrast-enhanced magnetic resonance imagingDynamic contrast-enhanced magnetic resonance imagingProgression-free survivalResponse Evaluation CriteriaAdvanced intrahepatic cholangiocarcinomaResonance imagingDied of diseaseResultsForty-four patientsProspective clinical trialPre-treatment DCE-MRILong-term outcomesDynamic magnetic resonance imagingSurvival updateStable diseasePartial responseMedian survivalRegional chemotherapy
2013
A Case Report of a Patient with Advanced Acinar Cell Carcinoma of the Pancreas: Long-Term Survival with Regional, Systemic and Targeted Therapy
Ang C, Herran L, Lagunes D, Klimstra D, Kemeny N. A Case Report of a Patient with Advanced Acinar Cell Carcinoma of the Pancreas: Long-Term Survival with Regional, Systemic and Targeted Therapy. Tumori Journal 2013, 99: e61-e64. PMID: 23748831, DOI: 10.1177/030089161309900230.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBevacizumabBiomarkers, TumorCamptothecinCarcinoma, Acinar CellCetuximabFluorodeoxyglucose F18FluorouracilHumansImmunohistochemistryLeucovorinLiver NeoplasmsMaleMolecular Targeted TherapyMultimodal ImagingOrganoplatinum CompoundsPancreatic NeoplasmsPositron-Emission TomographyRadiopharmaceuticalsTomography, X-Ray ComputedTreatment OutcomeConceptsAcinar cell carcinomaCell carcinomaAdvanced pancreatic acinar cell carcinomaPancreatic acinar cell carcinomaMolecular targeted agentsLong-term survivalRegional chemotherapyClinical courseTargeted therapyCase reportCarcinomaTherapyPatientsPancreasChemotherapyMalignancyLong-termRandom dataDiagnosisSurvival
2010
International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
Pagani O, Senkus E, Wood W, Colleoni M, Cufer T, Kyriakides S, Costa A, Winer EP, Cardoso F. International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? Journal Of The National Cancer Institute 2010, 102: 456-463. PMID: 20220104, PMCID: PMC3298957, DOI: 10.1093/jnci/djq029.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAntineoplastic Combined Chemotherapy ProtocolsBone NeoplasmsBreast NeoplasmsCatheter AblationChemotherapy, AdjuvantClinical Trials as TopicCongresses as TopicConsensus Development Conferences as TopicDose-Response Relationship, DrugEarly Detection of CancerEuropeFemaleGene Expression ProfilingHumansImmunosuppressive AgentsInterdisciplinary CommunicationInternational CooperationLiver NeoplasmsLung NeoplasmsNeoplasm StagingNeoplastic Cells, CirculatingObserver VariationPatient Care TeamPatient SelectionPractice Guidelines as TopicRadiotherapy, AdjuvantSurvival RateConceptsMetastatic breast cancerOligometastatic diseaseBreast cancerMetastatic lesionsPrimary tumorEuropean Breast Cancer ConferenceFirst consensus recommendationsOptimal local treatmentRapid disease controlAvailable therapeutic optionsSubset of patientsLong-term outcomesLarge retrospective seriesDetectable metastatic lesionsAttractive therapeutic strategyChemotherapy optionsSurvival benefitSystemic therapyTreatment guidelinesRegional chemotherapyRetrospective seriesTask ForceLung metastasesTherapeutic optionsPatient population
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply